Facebook
Twitter
LinkedIn
RSS
Home
About
Leadership
Board of Directors
CNS Clinical and Regulatory Advisory Board
Scientific Advisory Board
Pipeline
PH94B
Social Anxiety Disorder
Adjustment Disorder
Post-traumatic Stress Disorder
PH10
Major Depressive Disorder
AV-101
Major Depressive Disorder
Suicidal Ideation
Neuropathic Pain
Levodopa-Induced Dyskinesia (LID)
Epilepsy
VistaStem
Drug Rescue
Regenerative Medicine
Strategic Collaborators
Publications
AV-101 Publications
PH94B Publications
PH10 Publications
Finding Help
News & Media
Press Releases
Media Coverage
Multimedia - Photos & Videos
Investors
News / Events
Press Releases
IR Calendar
Email Alerts
Company Information
Overview
Leadership
Presentations
Contacts
FAQ
Overview
Stock Data
Overview
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Overview
Board of Directors
Board Committees
Governance Documents
Contact
Investors
Investors
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Leadership
Presentations
Contacts
FAQ
Overview
Stock Data
Overview
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10QSB
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-A12G
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SB-2
SC 13D
SC 13G
SC 13G/A
SC 14F1
SC 14F1/A
UPLOAD
Year:
View All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Date
Form
Description
PDF
XBRL
Pages
03/26/21
EFFECT
Notice of Effectiveness
1
03/22/21
4
Statement of changes in beneficial ownership of securities
2
03/22/21
4
Statement of changes in beneficial ownership of securities
2
03/22/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
5
03/15/21
S-3
Registration statement for specified transactions by certain issuers
Documents
EX-5.1
EX-23
44
03/05/21
8-K
Current report filing
Documents
EX-3.1
4
02/16/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
11
02/16/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
02/12/21
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
EX-99.A
5
02/12/21
8-K
Current report filing
Documents
EX-99.1
7
1
2
3
4
5
6
7
8
9
10
Email Updates
Be the first to receive news, events & updates
Sign Up